Drug Trial Radar · NCT05278663
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants
Last checked: Nov 19, 2026Latest source record: Sep 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Apr 14, 2022
Primary completion
Sep 4, 2023
Study completion Sep 4, 2023
Sponsor
- Lead sponsor
- Eisai Co., Ltd.Eisai
- Sponsor type
- Industry
- First posted
- Mar 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate the safety and tolerability of multiple oral doses of E6742 in participants with systemic lupus erythematosus (SLE).
Conditions
- Lupus Erythematosus, Systemic
Interventions
E6742Drug
E6742 tablet.
PlaceboOther
E6742-matching placebo tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Screening up to 28 days after the last dose of study drug at Day 85 (up to approximately 1 year 5 months)
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
National Hospital Organization Kyushu Medical Center
Fukuoka, Japan
Chukyo Hospital
Nagoya, Aichi-ken, Japan
Daido Clinic
Nagoya, Aichi-ken, Japan
Matsuyama Red Cross Hospital
Matsuyama, Ehime, Japan
Hospital of the University of Occupational and Environmental Health
Kitakyushu, Fukuoka, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Tohoku University Hospital
Sendai, Miyagi, Japan
Osaka University Hospital
Suita, Osaka, Japan
Juntendo University Hospital
Bunkyo-ku, Tokyo, Japan
St. Luke's International Hospital
Chuo-ku, Tokyo, Japan
Tokyo Metropolitan Hospital Organization Tokyo Metropolitan Tama Medical Center
Fuchū, Tokyo, Japan
Center Hospital of the National Center for Global Health and Medicine
Shinjuku-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.